S. Tempini

417 total citations
16 papers, 325 citations indexed

About

S. Tempini is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, S. Tempini has authored 16 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 12 papers in Epidemiology and 4 papers in Rheumatology. Recurrent topics in S. Tempini's work include Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Disease and Transplantation (6 papers). S. Tempini is often cited by papers focused on Hepatitis C virus research (12 papers), Liver Disease Diagnosis and Treatment (12 papers) and Liver Disease and Transplantation (6 papers). S. Tempini collaborates with scholars based in Italy and United Kingdom. S. Tempini's co-authors include G. Bellati, G. Idéo, A. Bellobuono, Luigi Roffi, Pierluigi Incerti, Salvatore Badalamenti, Francesco Salerno, Savino Bruno, L. Mondazzi and Enrico Maria Silini and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and British Journal of Clinical Pharmacology.

In The Last Decade

S. Tempini

16 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Tempini Italy 7 259 242 69 24 24 16 325
Kent C. Holtzmuller United States 11 241 0.9× 178 0.7× 63 0.9× 17 0.7× 18 0.8× 16 366
Sawako Kobayashi Japan 14 319 1.2× 334 1.4× 104 1.5× 13 0.5× 18 0.8× 37 543
E Frick Germany 7 154 0.6× 169 0.7× 120 1.7× 22 0.9× 10 0.4× 13 361
Hideko Kidokoro Japan 8 278 1.1× 252 1.0× 146 2.1× 40 1.7× 20 0.8× 13 305
Carine Chagneau-Derrode France 8 348 1.3× 331 1.4× 268 3.9× 16 0.7× 16 0.7× 14 457
Katharina Pomej Austria 11 238 0.9× 191 0.8× 71 1.0× 16 0.7× 9 0.4× 25 313
Laura Lemma Italy 7 264 1.0× 217 0.9× 92 1.3× 15 0.6× 12 0.5× 8 367
S. W. Schalm Netherlands 12 245 0.9× 220 0.9× 75 1.1× 13 0.5× 29 1.2× 21 330
Myung Seok Lee South Korea 12 197 0.8× 188 0.8× 78 1.1× 73 3.0× 11 0.5× 37 351
Eduard Veselíny Slovakia 10 149 0.6× 191 0.8× 48 0.7× 12 0.5× 9 0.4× 25 290

Countries citing papers authored by S. Tempini

Since Specialization
Citations

This map shows the geographic impact of S. Tempini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Tempini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Tempini more than expected).

Fields of papers citing papers by S. Tempini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Tempini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Tempini. The network helps show where S. Tempini may publish in the future.

Co-authorship network of co-authors of S. Tempini

This figure shows the co-authorship network connecting the top 25 collaborators of S. Tempini. A scholar is included among the top collaborators of S. Tempini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Tempini. S. Tempini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bellobuono, A., et al.. (2001). IFN alfa-CON 1 + Ribavirin combination therapy in naive difficult-to-treat patients affected by chronic hepatitis C. Journal of Hepatology. 34. 147–148. 1 indexed citations
2.
Zavaglia, Claudio, et al.. (2000). A Randomized, Controlled Study of Thymosin-α1 Therapy in Patients with Anti-HBe, HBV-DNA-Positive Chronic Hepatitis B. Digestive Diseases and Sciences. 45(4). 690–696. 29 indexed citations
3.
4.
Bellobuono, A., S. Tempini, G. Idéo, et al.. (2000). αIFN and ribavirin combination therapy reduces the occurrence of breakthrough in chronic hepatitis C. Journal of Hepatology. 32. 111–111. 6 indexed citations
5.
Bellobuono, A., et al.. (2000). Effect of 12 month αIFN and ribavirin combination therapy in chronic hepatitis C unresponsive to αIFN. Journal of Hepatology. 32. 178–178. 5 indexed citations
6.
7.
Bellobuono, A., et al.. (1997). Ribavirin and interferon‐α combination therapy vs interferon‐α alone in the retreatment of chronic hepatitis C: a randomized clinical trial. Journal of Viral Hepatitis. 4(3). 185–192. 54 indexed citations
8.
Bellobuono, A., L. Mondazzi, S. Tempini, Enrico Maria Silini, & G. Idéo. (1997). Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.. PubMed. 9(12). 1169–77. 8 indexed citations
9.
Bellobuono, A., et al.. (1997). Retreatment of chronic hepatitis C with ribavirin followed by interferon. Hepatology Research. 7(2). 130–135. 1 indexed citations
10.
Idéo, G., A. Bellobuono, L. Mondazzi, et al.. (1996). Alpha interferon treatment in chronic hepatitis C.. PubMed. 13 Suppl 13. S167–73. 9 indexed citations
11.
Idéo, G., A. Bellobuono, S. Tempini, et al.. (1996). Interferon treatment of chronic hepatitis C patients with normal or near normal alanine-amino-transferase levels: might it be harmful rather than useful?. International Hepatology Communications. 6(1). 8–15. 6 indexed citations
12.
Bellobuono, A., S. Tempini, G. Bellati, Enrico Maria Silini, & G. Idéo. (1995). HCV RNA serum levels, genotypes and response to alpha interferon treatment in chronic hepatitis C. Gastroenterology. 108(4). A1033–A1033. 8 indexed citations
13.
Salerno, Francesco, Salvatore Badalamenti, Pierluigi Incerti, et al.. (1987). Repeated paracentesis and i.v. albumin infusion to treat ‘tense’ ascites in cirrhotic patients. Journal of Hepatology. 5(1). 102–108. 135 indexed citations
14.
Tempini, S., G. Bellati, & G. Idéo. (1985). [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].. PubMed. 30(3). 255–61. 1 indexed citations
15.
Bellobuono, A., et al.. (1980). [Effect of acute administration of high doses of ethanol on the canalicular Na+K+ dependent ATPASE in the isolated and perfused rat liver].. PubMed. 56(18). 1833–6. 1 indexed citations
16.
Williams, Roger, J Chakraborty, J. English, et al.. (1978). Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability.. British Journal of Clinical Pharmacology. 5(6). 501–505. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kent C. Holtzmuller Breakdown of academic impact, for papers by Sawako Kobayashi Breakdown of academic impact, for papers by E Frick Breakdown of academic impact, for papers by Hideko Kidokoro Breakdown of academic impact, for papers by Carine Chagneau-Derrode Breakdown of academic impact, for papers by Katharina Pomej Breakdown of academic impact, for papers by Laura Lemma Breakdown of academic impact, for papers by S. W. Schalm Breakdown of academic impact, for papers by Myung Seok Lee Breakdown of academic impact, for papers by Eduard Veselíny
Rankless by CCL
2026